PEDIATRICS Vol. 104 No. 5 November 1999, pp. 1124-1125
| The first 20% of the full text of this article appears below. |
The article by Joffe and
colleagues1 that appeared in the September 1999 issue of Pediatrics discusses cost-effectiveness of
respiratory syncytial virus (RSV) prophylaxis among preterm infants.
This is based on a retrospective analysis of hospitalization rates from
RSV lower respiratory (tract) infection (LRI) in children with a
history of prematurity (
36 weeks' gestation) from July 1, 1991 through March 31, 1996. This analysis2 was published in
the October 1999 issue of Pediatrics. The population,
obtained from a large managed care database (Northern California Kaiser Permanente), is similar to that evaluated in clinical prevention trials of a hyperimmune globulin (RespiGam) and
This article has been cited by other articles:
![]() |
S. Joffe, T. A. Lieu, and G. J. Escobar The Critical Role of Population-Based Epidemiology in Cost-Effectiveness Research Pediatrics, April 1, 2000; 105(4): 862 - 863. [Full Text] |
||||